The 20th Annual Personalized Medicine Conference focuses on the evolving landscape of personalized medicine, including topics such as molecular diagnostics, partnerships, funding, regulatory challenges, and the future impact of genetic testing.
Executives and managers from biotech, pharmaceutical and diagnostics companies responsible for Translational Research, Genomics, Personalized Medicine, Companion Diagnostics, Bioinformatics, Molecular Diagnostics, Business Development, Biomarkers, Applied Genomics, Molecular Discovery, Proteomics, Next-Gen Sequencing, Marketing, Regulatory Affairs, Licensing and Strategic Partnering, as well as attendees from Consulting, Academia, Health Insurance Industry, Government, Investors and Healthcare Industry.
